{"top_spans": [[0, 0], [0, 1], [0, 3], [0, 4], [3, 3], [7, 11], [11, 11], [13, 13], [14, 16], [14, 18], [14, 20], [18, 18], [19, 19], [20, 20], [24, 24], [28, 33], [30, 30], [34, 34], [35, 41], [43, 44], [43, 51], [48, 48], [48, 51], [50, 51], [51, 51], [52, 52], [53, 53], [55, 55], [57, 57], [59, 65], [59, 66], [64, 64], [64, 65], [67, 67], [75, 75], [76, 76], [79, 80], [79, 85], [86, 86], [88, 88], [89, 89], [90, 90], [90, 92], [90, 97], [91, 92], [94, 97], [94, 98], [98, 98], [110, 110], [113, 113], [113, 115], [114, 115], [116, 116], [128, 128], [129, 129], [140, 140], [142, 142], [144, 146], [147, 147], [150, 153], [150, 155], [152, 152], [152, 155], [154, 155], [154, 158], [156, 156], [157, 158], [164, 164], [164, 165], [169, 169], [170, 170], [171, 180]], "predicted_antecedents": [-1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1, -1], "document": ["aelix", "therapeutics", "and", "gilead", "sciences", "enter", "into", "a", "clinical", "research", "collaboration", "agreement", "to", "evaluate", "a", "therapeutic", "vaccine", "and", "tlr7", "agonist", "regimen", "for", "hiv", "cure", "barcelona", "spain-", "business", "wire", "-oct", "18", "2018-aelix", "therapeutics", "s", "l", "aelix", "a", "clinical", "-", "stage", "biotechnology", "company", "specialized", "in", "the", "discovery", "and", "development", "of", "immunotherapies", "for", "hiv", "infection", "today", "announces", "that", "it", "has", "entered", "into", "a", "clinical", "research", "collaboration", "with", "gilead", "sciences", "inc", "gilead", "a", "research", "-", "based", "biopharmaceutical", "company", "that", "discovers", "develops", "and", "commercializes", "innovative", "medicines", "in", "areas", "of", "unmet", "medical", "need", "to", "jointly", "evaluate", "proprietary", "investigational", "products", "in", "a", "strategic", "clinical", "study", "aimed", "at", "achieving", "a", "functional", "cure", "of", "hiv", "infection", "clinical", "research", "collaboration", "gilead", "sciences", "inc", "cure", "instinctif", "partners", "vesatolimod", "cellular", "immunity", "group", "gilead", "sciences", "dr", "ian", "mcgowan", "aelix", "therapeutics", "hiv", "infection", "gilead", "spain", "vp", "medical", "affairs", "foster", "city", "clinical", "research", "mothe", "hiv", "aelix", "therapeutics", "aelix", "therapeutics", "virus", "gilead", "sciences", "gilead", "sciences", "inc", "california", "hti", "gilead", "sciences", "gilead", "sciences", "dr", "lance", "berman", "vaccine", "chief", "scientific", "officer", "of", "aelix", "therapeutics", "therapeutic", "vaccine", "barcelona", "john", "mchutchison", "dr", "christian", "brander", "chief", "scientific", "officer", "chief", "medical", "officer", "hivacat"], "clusters": []}